Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

975
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
975
Depression: Overview01:18

Depression: Overview

1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

820
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
820
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

868
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
868
Cognitive Therapy01:25

Cognitive Therapy

1.4K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.

Journal of psychopharmacology (Oxford, England)·2026
Same author

The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression.

Clinical pharmacology and therapeutics·2026
Same author

Hippocampal volume for prediction of working memory performance in patients with infantile hydrocephalus.

Journal of neurosurgery. Pediatrics·2026
Same author

Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations.

Expert opinion on drug metabolism & toxicology·2026
Same author

Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial.

JAMA psychiatry·2026
Same author

Intranasal Ketamine for Existential Distress in Advanced Cancer.

Journal of pain and symptom management·2026

Related Experiment Video

Updated: Mar 10, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K

Assessing and measuring cognitive function in major depressive disorder.

Renee-Marie Ragguett1, Danielle S Cha1,2, Ron Kakar1

  • 1Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.

Evidence-Based Mental Health
|December 10, 2016
PubMed
Summary

Cognitive dysfunction is common in major depressive disorder (MDD). Current screening tools lack sensitivity, but the THINC-it tool offers a promising solution for evaluating cognitive deficits in MDD patients.

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K

Related Experiment Videos

Last Updated: Mar 10, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Cognitive dysfunction is a significant symptom of major depressive disorder (MDD).
  • Existing assessment tools for cognitive dysfunction in MDD lack a gold standard and may not be adequately sensitive or specific.
  • The need for systematic screening and measurement tools is highlighted by the adoption of measurement-based care in MDD treatment.

Purpose of the Study:

  • To summarize the clinical implications of cognitive dysfunction in MDD.
  • To review existing screening, diagnostic, and measurement tools for cognitive dysfunction in MDD.
  • To introduce the THINC-it tool as a potential solution for unmet needs in cognitive assessment for MDD.

Main Methods:

  • Literature review of clinical implications and assessment tools for cognitive dysfunction in MDD.
  • Evaluation of the limitations of current measurement scales and digital tools.
  • Introduction and description of the THINC-it screening tool.

Main Results:

  • Current measurement scales for cognitive dysfunction in MDD have limitations, including lack of MDD specificity and cost barriers for digital tools.
  • Existing tests often fail to represent the full spectrum of cognitive dysfunction in MDD, leading to insufficient screening sensitivity.
  • The THINC-it tool is presented as a novel screening instrument designed to address these identified limitations.

Conclusions:

  • There is a critical need for improved and sensitive tools to assess cognitive dysfunction in patients with major depressive disorder.
  • Limitations in current screening methods necessitate the development and validation of more targeted instruments.
  • Understanding the shortcomings of existing tools allows for more informed cognitive screening in MDD.